Cargando…
Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022
The risk for developing cardiovascular diseases (CVD) in rheumatoid arthritis (RA) patients is 1.5 times higher compared to the general population. This risk is partly due to the contribution of systemic inflammation in increased atherogenesis, while an increased prevalence of “traditional” cardiova...
Autores principales: | Dijkshoorn, Bas, Raadsen, Reinder, Nurmohamed, Michael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142998/ https://www.ncbi.nlm.nih.gov/pubmed/35628831 http://dx.doi.org/10.3390/jcm11102704 |
Ejemplares similares
-
Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients
por: Blanken, Annelies B., et al.
Publicado: (2022) -
Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated
por: Raadsen, Reinder, et al.
Publicado: (2023) -
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
por: Hansildaar, Romy, et al.
Publicado: (2021) -
The increased cardiovascular risk in rheumatoid arthritis: when does it start?
por: Nurmohamed, Michael T
Publicado: (2010) -
Prorenin anno 2008
por: Danser, A. H. Jan, et al.
Publicado: (2008)